Pacific Biosciences of California Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $14.55 on 07/18/23 and a low of $1.25 for the same time frame on 04/17/24.
52-week price history of PACB Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Pacific Biosciences of California Inc’s current trading price is -89.28% away from its 52-week high, while its distance from the 52-week low is 24.80%. The stock’s price range during the 52-week period has remained between $1.25 and $14.55. In the Healthcare sector, the company’s shares saw a trading volume of around 8.89 million for the day, which was evidently lower than the average daily volume of 9.74 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Pacific Biosciences of California Inc (PACB) has experienced a quarterly decline of -77.33% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 424.76M and boasts a workforce of 796 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 6.1338, with a change in price of -6.8800. Similarly, Pacific Biosciences of California Inc recorded 8,793,396 in trading volume during the last 100 days, posting a change of -81.52%.
Examining PACB’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for PACB stands at 1.33. Similarly, the long-term debt-to-equity ratio is also 1.32.
PACB Stock Stochastic Average
As of today, Pacific Biosciences of California Inc’s raw stochastic average for the last 50 days stands at 5.56%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 11.74%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 10.16% and 7.62%, respectively.
PACB Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant loss of -84.10% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -79.03%. Over the past 30 days, the price of PACB has leaped by -59.38%. And in the last five days, it has fallen by -44.97%.
